Verge Genomics
We use human data and AI to develop better drugs faster.
Founders
Not read from YC yet; the weekly run fills these in.
Same space
Competitors
Closest in what they build, same category.
Adjacent
Overlapping tags, a different niche.
Parallel BioS21Using the immune system to cure diseaseShared: drug, human, biologyActive
Strand AIW26Multimodal foundation models to predict uncollected patient biologyShared: drug, develop, biologyActive
Persist AIW23Developing long-lasting drug formulations 50% fasterShared: drug, develop, usesActive
Talus BioS21Discovering drugs that target the DNA regulomeShared: drug, human, artificialActive
OriginW26AI and Data for Cancer TherapeuticsShared: drug, dataset, dataActive
Also from S15 in AI
Batchmates in Summer 2015.
Auro RoboticsS15Autonomous shuttles for campus-like environments.Acquired
Blitz EsportsS15Blitz breaks down the complex world of esports and offers new…Acquired
Drip CapitalS15Digital trade finance and B2B commerce companyActive
FountainS15High volume hiring made simpleActive
IroncladS15AI-powered contract managementActive
KlarismoS15Klarismo turns your body into an interactive experience. We built a…Inactive
About Verge Genomics
Verge uses artificial intelligence and human data to develop better drugs faster. Verge has an end-to-end technology-driven drug discovery and development platform, featuring one of the field’s largest and most comprehensive proprietary patient genomics datasets from human tissue. Verge uses machine learning to mine this data and develops these insights into new drugs using it’s human-centric biology and chemistry platforms.
San Francisco, CA, USA
Verge Genomics: questions
Which YC batch was Verge Genomics in?
Verge Genomics was in Y Combinator's Summer 2015 batch (S15).
Is Verge Genomics still active?
Y Combinator lists Verge Genomics as active.
Where is Verge Genomics based?
Verge Genomics lists San Francisco, CA, USA as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.